Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituximab Versus Mycophenolate Mofetil in Children With Steriod-dependent Nephrotic Syndrome: A Single-center, Randomized Controlled Trial

NCT05843968 is registered in ClinicalTrials.gov with Children's Hospital of Chongqing Medical University as lead sponsor.

NCT NCT05843968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05843968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituximab Versus Mycophenolate Mofetil in Children With Steriod-dependent Nephrotic Syndrome: A Single-center, Randomized Controlled Trial
Lead sponsor
Children's Hospital of Chongqing Medical University
Phase
Phase 2
Overall status
Unknown status
Start date
January 29, 2023
Completion date
July 1, 2026
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nephrotic syndrome in children